Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Psychosoc Nurs Ment Health Serv ; 61(2): 27-37, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35858205

ABSTRACT

Application (app)-based interventions using smartphones could provide effective alternatives to traditional treatment programs during and beyond the coronavirus disease 2019 pandemic. The current quasi-experimental study with a non-equivalent comparison group tested the effects of a smartphone app-based metacognitive intervention program with weekly mentoring sessions on the meta-cognitive beliefs, psychotic symptoms, and social functioning of individuals with schizophrenia from community psychosocial rehabilitation centers. The study was conducted with 20 participants with severe psychotic symptoms and low social functioning and 24 participants with relatively light psychotic symptoms and good social functioning as a comparison group. For the experimental group, the app-based intervention was combined with weekly contact mentoring sessions over 10 weeks. The comparison group received only the app-based intervention over 10 weekly sessions. No differences were observed between groups' total scores; however, the experimental group showed a tendency toward improved psychotic symptoms and social functioning over time, unlike the comparison group. These findings provide an empirical basis for managing schizophrenia symptoms with smartphone apps. [Journal of Psychosocial Nursing and Mental Health Services, 61(2), 27-37.].


Subject(s)
COVID-19 , Mentoring , Psychotic Disorders , Schizophrenia , Humans , Smartphone , Schizophrenia/therapy , Psychotic Disorders/therapy , Psychotic Disorders/diagnosis
2.
Arch Psychiatr Nurs ; 41: 43-50, 2022 12.
Article in English | MEDLINE | ID: mdl-36428074

ABSTRACT

This study investigated the effectiveness of a metacognitive intervention program for symptom relief and improvement in social cognitive functioning among adults with schizophrenia. The program focused on enhancing metacognition to encourage self-awareness and step-by-step perspective expansion. There were 24 participants in the experimental group and 19 participants in the control group. Delusions decreased, and social cognition and social functioning improved in the experimental group compared to the control group. The program demonstrated utility as a treatment modality, which can be part of an overall program of a mental health promotion institution to improve functioning in patients with schizophrenia.


Subject(s)
Metacognition , Schizophrenia , Adult , Humans , Schizophrenia/therapy , Schizophrenia/diagnosis , Schizophrenic Psychology , Social Interaction , Cognition
3.
Article in English | MEDLINE | ID: mdl-34202408

ABSTRACT

Metacognition is a higher-level cognition of identifying one's own mental status, beliefs, and intentions. This research comprised a survey of 184 people with schizophrenia to verify the reliability of the metacognitive rating scale (MCRS) with the revised and supplemented metacognitions questionnaire (MCQ) to measure the dysfunctional metacognitive beliefs of people with schizophrenia by adding the concepts of anger and anxiety. This study analyzed the data using principal component analysis and the varimax method for exploratory factor analysis. To examine the reliability of the extracted factors, Cronbach's α was used. According to the results, reliability was ensured for five factors: positive beliefs about worry, negative beliefs about uncontrollability and danger of worry, cognitive confidence, need for control, and cognitive self-consciousness. The negative beliefs about uncontrollability and danger of worry and the need for control on anger expression, which were both added in this research, exhibited the highest correlation (r = 0.727). The results suggest that the MCRS is a reliable tool to measure the metacognition of people with schizophrenia.


Subject(s)
Metacognition , Schizophrenia , Anxiety Disorders , Humans , Reproducibility of Results , Republic of Korea , Surveys and Questionnaires
4.
Article in English | MEDLINE | ID: mdl-32290397

ABSTRACT

This research examined the relationship between psychotic symptoms, social cognition, and job retention among people with schizophrenia in Korea. Participants (158 people with schizophrenia from 15 mental health institutions) were divided into two groups: those with a job retention period of less than six months (n = 75), and those with a job retention period of six months or more (n = 83). Participants completed a survey packet containing the Brief Psychiatric Rating Scale (BPRS), Global Assessment of Function (GAF) Scale, Interpersonal Relationship Functioning Assessment Scale, Basic Empathy Scale, Hinting Task, and Ambiguous Intention Hostility Questionnaire (AIHQ), and provided their job retention status. We used binomial logistic regression analysis to examine whether job retention was affected by participants' demographic, clinical, and vocational characteristics, as well as the three components of social cognition, i.e., theory of mind, empathy, and attribution style. Results showed that theory of mind (ToM), attribution style, and psychotic symptoms explained 52.7% of the variance in job retention. A higher theory of mind means a higher ability to grasp the intentions of others. The higher theory of mind, the lesser attribution style, and the lesser psychotic symptoms were related to a longer period of job retention.


Subject(s)
Schizophrenia/epidemiology , Work/psychology , Cognition , Female , Humans , Male , Neuropsychological Tests , Psychiatric Status Rating Scales , Psychotic Disorders/epidemiology , Republic of Korea/epidemiology , Schizophrenic Psychology , Social Perception , Theory of Mind
5.
Arch Psychiatr Nurs ; 34(1): 19-26, 2020 02.
Article in English | MEDLINE | ID: mdl-32035584

ABSTRACT

Considering that the prevalence of cardio-metabolic syndrome in patients with chronic schizophrenia is two or three times higher than the general population, this study aimed to provide patients with schizophrenia using community psychiatric rehabilitation services with therapeutic lifestyle change (TLC) mentoring using a smartphone application and provide inpatients in a psychiatric ward with structured TLC mentoring, to compare improvement in cardio-metabolic factors between the two groups. The home-based community service users using a TLC application were more likely to experience an improvement in their cardio-metabolic factors than the inpatients provided with the structured TLC program.


Subject(s)
Life Style , Mentoring , Metabolic Syndrome/epidemiology , Schizophrenia/rehabilitation , Adult , Body Mass Index , Female , Humans , Inpatients/statistics & numerical data , Lipids , Male , Metabolic Syndrome/prevention & control , Mobile Applications , Prevalence , Smartphone , Waist Circumference
6.
Arch Psychiatr Nurs ; 33(4): 329-336, 2019 08.
Article in English | MEDLINE | ID: mdl-31280776

ABSTRACT

Mobile technology is a popular intervention mode for patients with schizophrenia because of its accessibility and functionality. We examined patients' willingness to use smartphone apps for lifestyle management and its effect on self-reported lifestyle habits. Five hundred fifty-five inpatients from various mental health institutions participated. Willingness to use smartphone apps was associated with age, education, income, device type, and body mass index. Positive opinions on smartphone app use were significantly associated with willingness to use apps, which was significantly associated with dietary and living habits. Thus, improving willingness to use apps can help patients improve their lifestyle, potentially preventing relapse.


Subject(s)
Chronic Disease/therapy , Life Style , Mobile Applications , Patient Acceptance of Health Care/psychology , Schizophrenia/therapy , Smartphone , Adult , Feeding Behavior , Female , Humans , Male , Middle Aged , Republic of Korea , Self Report , Surveys and Questionnaires
7.
Mediators Inflamm ; 2019: 6217548, 2019.
Article in English | MEDLINE | ID: mdl-30944547

ABSTRACT

Liver X receptors (LXRs) have emerged as important regulators of inflammatory gene expression. Previously, we had reported that an LXRα gene promoter polymorphism (-1830 T > C) is associated with systemic lupus erythematosus (SLE). Therefore, we assessed cytokine expression in relation to LXRα polymorphism in monocyte-derived macrophages from patients with SLE. Macrophages were obtained after 72 hours of culture of human monocytes supplemented with phorbol 12-myristate 13-acetate. Cells were transfected with LXRα promoter constructs. Additionally, peripheral blood mononuclear cell- (PBMC-) derived macrophages from the patients were evaluated for proinflammatory cytokines in relation to the genotypes of LXRα -1830 T > C. The expression of LXRα was increased in macrophages; levels of proinflammatory cytokines were decreased with LXRα expression. Production of proinflammatory cytokines varied depending on LXRα -1830 T > C genotype. In particular, expression of LXRα was decreased and that of proinflammatory cytokines was increased for LXRα -1830 TC genotype compared to that for TT genotype. The data were consistent in PBMC-derived macrophages from patients with SLE. Increased proinflammatory cytokines is related to TLR7 and TLR9 expression. These data suggest that the expression levels of LXRα, according to LXRα -1830 T > C genotype, may contribute to the inflammatory response by induction of inflammatory cytokines in SLE.


Subject(s)
Leukocytes, Mononuclear/metabolism , Liver X Receptors/genetics , Liver X Receptors/metabolism , Macrophages/metabolism , Benzoates/pharmacology , Benzylamines/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line, Tumor , Cytokines/metabolism , Genotype , Humans , Hydrocarbons, Fluorinated/pharmacology , Immunoblotting , Leukocytes, Mononuclear/drug effects , Liver X Receptors/agonists , Macrophages/drug effects , Real-Time Polymerase Chain Reaction , Sulfonamides/pharmacology , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 9/genetics , Toll-Like Receptor 9/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...